Pharmanutra Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	21.16	18.58	15.49	18.93	22.05	29.41
Short-Term Investments	7.84	12.04	13.48	6.19	4.81	4.53
Cash & Short-Term Investments	29	30.62	28.97	25.12	26.86	33.94
Cash Growth	-5.71%	5.67%	15.34%	-6.49%	-20.86%	63.14%
Accounts Receivable	28.26	24.76	22.05	19.22	21.65	16.67
Other Receivables	8.92	2.43	2.1	2.7	2.12	0.99
Receivables	37.18	27.2	24.15	21.92	23.77	17.66
Inventory	8.48	8.85	6.94	8.17	5.26	2.87
Prepaid Expenses	-	2.1	0.68	1.06	0.93	0.15
Other Current Assets	-	4.14	4.26	2.42	1.9	0.9
Total Current Assets	74.67	72.9	65.01	58.68	58.73	55.52
Property, Plant & Equipment	24.07	24.13	25.66	26.36	17.06	8.37
Long-Term Investments	-	0	0	0	0	0.25
Goodwill	-	17.56	17.56	17.56	17.56	2.75
Other Intangible Assets	24.66	3.81	3.71	3.73	3.15	2.45
Long-Term Deferred Tax Assets	-	2.15	1.4	1.52	1.31	1.24
Long-Term Deferred Charges	-	0.68	0.67	0.08	-	-
Other Long-Term Assets	4.73	3.99	3.39	4.5	2.36	0.77
Total Assets	128.13	125.23	117.41	112.44	100.16	71.36
Accounts Payable	17.51	17.36	13.5	13.66	14.89	8.49
Accrued Expenses	-	4.19	3.81	3.23	2.83	2.6
Short-Term Debt	-	0.6	0.41	0.63	-	-
Current Portion of Long-Term Debt	4.66	4.06	4.04	3.59	3.37	0.56
Current Portion of Leases	-	0.41	0.32	0.37	0.25	0.26
Current Income Taxes Payable	-	0.89	1.96	2.18	0.98	2.92
Current Unearned Revenue	-	2.54	2.3	2.45	2	1.26
Other Current Liabilities	9.23	0.99	1.02	1.55	1.48	0.66
Total Current Liabilities	31.4	31.03	27.34	27.65	25.79	16.75
Long-Term Debt	14.44	14.35	18.15	22.19	13.61	5
Long-Term Leases	-	1.1	1.36	1.24	0.5	0.53
Pension & Post-Retirement Benefits	-	1.36	1.33	1.21	1.07	2.52
Other Long-Term Liabilities	7.82	6.15	7.09	5.75	8.23	1.48
Total Liabilities	53.65	53.99	55.27	58.04	49.21	26.27
Common Stock	74.47	1.12	1.12	1.12	1.12	1.12
Retained Earnings	-	20	16.61	12.83	15.27	14
Treasury Stock	-	-5.9	-4.56	-4.01	-	-
Comprehensive Income & Other	-	56.01	48.97	44.47	34.55	29.96
Shareholders' Equity	74.47	71.24	62.14	54.41	50.95	45.08
Total Liabilities & Equity	128.13	125.23	117.41	112.44	100.16	71.36
Total Debt	19.1	20.51	24.27	28.02	17.73	6.35
Net Cash (Debt)	9.91	10.1	4.7	-2.9	9.14	27.59
Net Cash Growth	47.74%	114.91%	-	-	-66.89%	44.14%
Net Cash Per Share	1.04	1.05	0.49	-0.30	0.94	2.85
Filing Date Shares Outstanding	9.6	9.58	9.6	9.61	9.62	9.68
Total Common Shares Outstanding	9.6	9.58	9.6	9.61	9.64	9.68
Working Capital	43.28	41.87	37.67	31.03	32.94	38.77
Book Value Per Share	7.76	7.44	6.47	5.66	5.28	4.66
Tangible Book Value	49.82	49.87	40.86	33.11	30.24	39.88
Tangible Book Value Per Share	5.19	5.21	4.26	3.44	3.14	4.12
Land	-	20.74	20.65	20.42	0.75	0.64
Machinery	-	8.08	7.61	6.86	3.26	2.85
Construction In Progress	-	0.31	0.16	0.13	14.92	6.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.